Logo image of OLPX

OLAPLEX HOLDINGS INC (OLPX) Stock Fundamental Analysis

NASDAQ:OLPX - Nasdaq - US6793691089 - Common Stock - Currency: USD

1.34  0 (0%)

After market: 1.34 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to OLPX. OLPX was compared to 35 industry peers in the Personal Care Products industry. OLPX has only an average score on both its financial health and profitability. OLPX has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

OLPX had positive earnings in the past year.
OLPX had a positive operating cash flow in the past year.
Each year in the past 5 years OLPX has been profitable.
OLPX had a positive operating cash flow in each of the past 5 years.
OLPX Yearly Net Income VS EBIT VS OCF VS FCFOLPX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

OLPX has a Return On Assets of 0.69%. This is comparable to the rest of the industry: OLPX outperforms 54.29% of its industry peers.
Looking at the Return On Equity, with a value of 1.39%, OLPX is in the better half of the industry, outperforming 62.86% of the companies in the same industry.
With a Return On Invested Capital value of 2.86%, OLPX perfoms like the industry average, outperforming 45.71% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for OLPX is significantly below the industry average of 15.14%.
The 3 year average ROIC (8.40%) for OLPX is well above the current ROIC(2.86%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 0.69%
ROE 1.39%
ROIC 2.86%
ROA(3y)6.34%
ROA(5y)7.22%
ROE(3y)13.59%
ROE(5y)18.06%
ROIC(3y)8.4%
ROIC(5y)9.93%
OLPX Yearly ROA, ROE, ROICOLPX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 100 200 300 400

1.3 Margins

OLPX has a Profit Margin (2.91%) which is in line with its industry peers.
In the last couple of years the Profit Margin of OLPX has declined.
With a decent Operating Margin value of 15.16%, OLPX is doing good in the industry, outperforming 77.14% of the companies in the same industry.
In the last couple of years the Operating Margin of OLPX has declined.
OLPX has a better Gross Margin (70.42%) than 65.71% of its industry peers.
In the last couple of years the Gross Margin of OLPX has declined.
Industry RankSector Rank
OM 15.16%
PM (TTM) 2.91%
GM 70.42%
OM growth 3Y-33.32%
OM growth 5Y-23.34%
PM growth 3Y-49.98%
PM growth 5Y-35.41%
GM growth 3Y-3.57%
GM growth 5Y-2.1%
OLPX Yearly Profit, Operating, Gross MarginsOLPX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), OLPX is creating some value.
The number of shares outstanding for OLPX has been increased compared to 1 year ago.
Compared to 5 years ago, OLPX has more shares outstanding
The debt/assets ratio for OLPX has been reduced compared to a year ago.
OLPX Yearly Shares OutstandingOLPX Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 200M 400M 600M
OLPX Yearly Total Debt VS Total AssetsOLPX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 1.82 indicates that OLPX is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of OLPX (1.82) is worse than 65.71% of its industry peers.
The Debt to FCF ratio of OLPX is 7.08, which is on the high side as it means it would take OLPX, 7.08 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 7.08, OLPX is doing good in the industry, outperforming 62.86% of the companies in the same industry.
A Debt/Equity ratio of 0.73 indicates that OLPX is somewhat dependend on debt financing.
OLPX has a worse Debt to Equity ratio (0.73) than 65.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 7.08
Altman-Z 1.82
ROIC/WACC0.35
WACC8.19%
OLPX Yearly LT Debt VS Equity VS FCFOLPX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

OLPX has a Current Ratio of 10.74. This indicates that OLPX is financially healthy and has no problem in meeting its short term obligations.
OLPX has a better Current ratio (10.74) than 100.00% of its industry peers.
OLPX has a Quick Ratio of 9.53. This indicates that OLPX is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of OLPX (9.53) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 10.74
Quick Ratio 9.53
OLPX Yearly Current Assets VS Current LiabilitesOLPX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

6

3. Growth

3.1 Past

OLPX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -42.86%.
OLPX shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -20.10% yearly.
The Revenue has decreased by -5.11% in the past year.
OLPX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 23.32% yearly.
EPS 1Y (TTM)-42.86%
EPS 3Y-54.93%
EPS 5Y-20.1%
EPS Q2Q%-100%
Revenue 1Y (TTM)-5.11%
Revenue growth 3Y-10.94%
Revenue growth 5Y23.32%
Sales Q2Q%-1.95%

3.2 Future

The Earnings Per Share is expected to decrease by -13.42% on average over the next years. This is quite bad
The Revenue is expected to grow by 29.95% on average over the next years. This is a very strong growth
EPS Next Y-41.28%
EPS Next 2Y-18.29%
EPS Next 3Y-13.42%
EPS Next 5YN/A
Revenue Next Year2.36%
Revenue Next 2Y2.31%
Revenue Next 3Y3.32%
Revenue Next 5Y29.95%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
OLPX Yearly Revenue VS EstimatesOLPX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
OLPX Yearly EPS VS EstimatesOLPX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

OLPX is valuated correctly with a Price/Earnings ratio of 16.75.
OLPX's Price/Earnings ratio is a bit cheaper when compared to the industry. OLPX is cheaper than 74.29% of the companies in the same industry.
OLPX's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.60.
A Price/Forward Earnings ratio of 18.25 indicates a rather expensive valuation of OLPX.
65.71% of the companies in the same industry are more expensive than OLPX, based on the Price/Forward Earnings ratio.
OLPX is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.39, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.75
Fwd PE 18.25
OLPX Price Earnings VS Forward Price EarningsOLPX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of OLPX indicates a somewhat cheap valuation: OLPX is cheaper than 77.14% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, OLPX is valued cheaper than 91.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.74
EV/EBITDA 8.21
OLPX Per share dataOLPX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

OLPX's earnings are expected to decrease with -13.42% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-18.29%
EPS Next 3Y-13.42%

More info and screens

0

5. Dividend

5.1 Amount

OLPX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OLAPLEX HOLDINGS INC

NASDAQ:OLPX (6/12/2025, 8:19:21 PM)

After market: 1.34 0 (0%)

1.34

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)08-04 2025-08-04/bmo
Inst Owners14.56%
Inst Owner Change-0.07%
Ins Owners1.62%
Ins Owner Change31.31%
Market Cap892.33M
Analysts51.43
Price Target2.11 (57.46%)
Short Float %6.97%
Short Ratio6.69
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-15.48%
Min EPS beat(2)-100%
Max EPS beat(2)69.03%
EPS beat(4)1
Avg EPS beat(4)-10.57%
Min EPS beat(4)-100%
Max EPS beat(4)69.03%
EPS beat(8)4
Avg EPS beat(8)-4.95%
EPS beat(12)8
Avg EPS beat(12)-0.02%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)6.87%
Min Revenue beat(2)1.35%
Max Revenue beat(2)12.38%
Revenue beat(4)2
Avg Revenue beat(4)1.15%
Min Revenue beat(4)-7.47%
Max Revenue beat(4)12.38%
Revenue beat(8)5
Avg Revenue beat(8)-0.82%
Revenue beat(12)7
Avg Revenue beat(12)-1.02%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.52%
PT rev (3m)-2.57%
EPS NQ rev (1m)-15.37%
EPS NQ rev (3m)-58.99%
EPS NY rev (1m)-6.57%
EPS NY rev (3m)-43.61%
Revenue NQ rev (1m)-0.29%
Revenue NQ rev (3m)1.23%
Revenue NY rev (1m)0.62%
Revenue NY rev (3m)4.63%
Valuation
Industry RankSector Rank
PE 16.75
Fwd PE 18.25
P/S 2.12
P/FCF 9.74
P/OCF 9.25
P/B 1.02
P/tB N/A
EV/EBITDA 8.21
EPS(TTM)0.08
EY5.97%
EPS(NY)0.07
Fwd EY5.48%
FCF(TTM)0.14
FCFY10.27%
OCF(TTM)0.14
OCFY10.81%
SpS0.63
BVpS1.32
TBVpS-0.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.69%
ROE 1.39%
ROCE 3.74%
ROIC 2.86%
ROICexc 4.33%
ROICexgc 70.3%
OM 15.16%
PM (TTM) 2.91%
GM 70.42%
FCFM 21.78%
ROA(3y)6.34%
ROA(5y)7.22%
ROE(3y)13.59%
ROE(5y)18.06%
ROIC(3y)8.4%
ROIC(5y)9.93%
ROICexc(3y)11%
ROICexc(5y)12.02%
ROICexgc(3y)125.03%
ROICexgc(5y)244.84%
ROCE(3y)11%
ROCE(5y)12.99%
ROICexcg growth 3Y-27.54%
ROICexcg growth 5Y-25.57%
ROICexc growth 3Y-37.52%
ROICexc growth 5Y-59.98%
OM growth 3Y-33.32%
OM growth 5Y-23.34%
PM growth 3Y-49.98%
PM growth 5Y-35.41%
GM growth 3Y-3.57%
GM growth 5Y-2.1%
F-Score6
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 7.08
Debt/EBITDA 5.49
Cap/Depr 9.02%
Cap/Sales 1.14%
Interest Coverage 1.1
Cash Conversion 82.4%
Profit Quality 748.64%
Current Ratio 10.74
Quick Ratio 9.53
Altman-Z 1.82
F-Score6
WACC8.19%
ROIC/WACC0.35
Cap/Depr(3y)7.27%
Cap/Depr(5y)5.1%
Cap/Sales(3y)0.78%
Cap/Sales(5y)0.53%
Profit Quality(3y)364.56%
Profit Quality(5y)302.34%
High Growth Momentum
Growth
EPS 1Y (TTM)-42.86%
EPS 3Y-54.93%
EPS 5Y-20.1%
EPS Q2Q%-100%
EPS Next Y-41.28%
EPS Next 2Y-18.29%
EPS Next 3Y-13.42%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.11%
Revenue growth 3Y-10.94%
Revenue growth 5Y23.32%
Sales Q2Q%-1.95%
Revenue Next Year2.36%
Revenue Next 2Y2.31%
Revenue Next 3Y3.32%
Revenue Next 5Y29.95%
EBIT growth 1Y-31.54%
EBIT growth 3Y-40.62%
EBIT growth 5Y-5.47%
EBIT Next Year-16.39%
EBIT Next 3Y-2.83%
EBIT Next 5YN/A
FCF growth 1Y-59.91%
FCF growth 3Y-11.33%
FCF growth 5Y21.31%
OCF growth 1Y-58.32%
OCF growth 3Y-10.57%
OCF growth 5Y22.16%